ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network
Article in Aging (December 2023)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in Aging (December 2023)
Article in Pathology - Research and Practice (November 2023)
Article in F1000Research (October 2023)